Circulating Tumor Cells (CTC) in Cancer

Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Aug 17, 2020

Keywords

ClinConnect Summary

This clinical trial is studying circulating tumor cells (CTCs) in cancer patients. CTCs are cancer cells that have detached from a tumor and are found in the bloodstream. Researchers want to learn more about how these cells behave and what they can tell us about different types of cancer. By examining CTCs at various stages of the disease, the study aims to understand their role as potential markers for cancer and identify important signaling networks that may be active in these cells.

To participate in this study, you must be an adult with a confirmed diagnosis of solid tumor cancer, which includes types like adenocarcinoma or sarcoma. Unfortunately, patients with blood cancers or precancerous conditions are not eligible. Participants will need to provide written consent and have a pathology report confirming their diagnosis. If you join the trial, you can expect to have your CTCs collected and analyzed at different points in your treatment. This research could help improve our understanding of cancer and lead to better diagnosis and treatment options in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult cancer patients
• • All patients with histology-based proved diagnosis of cancer, all stages and subtypes can be included. Precancerous lesions cannot be included.
• • All patients with the diagnosis of a solid tumor including adenocarcinoma, squamous cell carcinoma, neuroendocrine carcinoma, sarcoma
• • Written pathology report must be available.
• • Written informed consent.
• Exclusion Criteria:
• • No written informed consent.
• • No proved diagnosis of malignancy by pathology report.
• • Patients with the diagnosis of blood cancer